StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Vaccinex's market cap was $2.68M on Oct 19, 2026, against $1.69M a year earlier. Over the last 5 years it ranged from $1.34M to $73.92M, with a median of $7.86M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$2.68M-7.0%
2025Dec 31, 2025$2.88M+13.0%
2024Dec 31, 2024$2.55M-20.5%
2023Dec 29, 2023$3.21M-88.3%
2022Dec 30, 2022$27.30M-14.8%
2021Dec 31, 2021$32.03M-30.9%
2020Dec 31, 2020$46.33M-16.8%
2019Dec 31, 2019$55.68M+33.3%
2018Dec 31, 2018$41.77M–

More Vaccinex figures

See a number that looks wrong?